13-Dec-2024
Nano-X Imaging Secures Shareholder Approval for Key Proposals
TipRanks (Fri, 13-Dec 4:28 PM ET)
Nano-X Imaging’s (NNOX) Shares Surge on FDA Approval but Have Yet to Reach Profitability
TipRanks (Wed, 11-Dec 4:37 AM ET)
Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication
Globe Newswire (Thu, 5-Dec 5:55 AM ET)
Nanox Announces Third Quarter of 2024 Financial Results and Provides Business Update
Globe Newswire (Thu, 21-Nov 8:00 AM ET)
Nanox to Report Third Quarter and Financial Results on November 21, 2024
Globe Newswire (Mon, 11-Nov 4:05 PM ET)
Nanox Highlighted on TIME's Best Inventions of 2024 List for its AI Solutions
Globe Newswire (Thu, 31-Oct 8:00 AM ET)
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.
Nano X Imaging trades on the NASDAQ stock market under the symbol NNOX.
As of December 13, 2024, NNOX stock price declined to $6.89 with 3,214,739 million shares trading.
NNOX has a beta of 1.11, meaning it tends to be more sensitive to market movements. NNOX has a correlation of 0.01 to the broad based SPY ETF.
NNOX has a market cap of $397.78 million. This is considered a Small Cap stock.
Last quarter Nano X Imaging reported $3 million in Revenue and -$.15 earnings per share. This fell short of revenue expectation by $-499,000 and met earnings estimates .
In the last 3 years, NNOX traded as high as $22.69 and as low as $4.89.
The top ETF exchange traded funds that NNOX belongs to (by Net Assets): IWM, IWO, IZRL, VTWO, IWC.
NNOX has underperformed the market in the last year with a return of +1.8%, while SPY returned +29.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NNOX shares. However, NNOX has outperformed the market in the last 3 month and 2 week periods, returning +9.0% and +6.7%, while SPY returned +7.8% and +0.3%, respectively. This indicates NNOX has been having a stronger performance recently.
NNOX support price is $6.94 and resistance is $7.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NNOX shares will trade within this expected range on the day.